MNTA - This might be the Patent referred to that detects heparin contaminants -
EVALUATING HEPARIN PREPARATIONS FOR PHARMACEUTICAL USE
The disclosure features methods of analyzing preparations of heparin, and materials derived from heparin using strong anion exchange high performance liquid chromatography; The invention relates to methods of analyzing samples heparin, and materials derived from heparin.
The method can include making a decision, e.g., to classify, select, accept or discard, release or withhold, process into a drug product, ship, move to a different location, formulate, label, package, release into commerce, sell or offer for sale the preparation, based, at least in part, upon the analysis.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.